Boehringer Ingelheim Competitors and Similar CompaniesClear all
Daiichi Sankyo's competitors and similar companies include Zoetis, AstraZeneca and GSK.
 Daiichi Sankyo Daiichi Sankyo (第一三共株式会社) is a company specializing in the research, development, and manufacture of innovative pharmaceutical products. |  Zoetis Zoetis (formerly known as Pfizer Animal Health) is an animal health company focusing on the discovery, development, manufacture, and commercialization of medicines, vaccines, and diagnostic products and services. |  AstraZeneca AstraZeneca is a biopharmaceutical company specializing in the discovery, development, manufacturing, and marketing of prescription medicines. |  GSK GSK (GlaxoSmithKline) is a science-led healthcare company that researches, develops, and manufactures pharmaceutical medicines, vaccines, and consumer healthcare products. | |
Founding Date | Founding Date 2005 | Founding Date 1952 | Founding Date 1999 | Founding Date 2000 |
Type | Type Public | Type Public | Type Public | Type Public |
Tags | ||||
Locations | Locations Tokyo, JP HQ Macquarie Park, AU Wien, AT Braine L'alleud, BE Sao Paulo, BR Toronto, CA Shanghai, CN see more | Locations Parsippany, US HQ Buenos Aires, AR Villa Adelina, AR Silverwater, AU Wien, AT Ottignies Louvain La Neuve, BE Zaventem, BE see more | Locations Cambridge, GB HQ Alger, DZ Buenos Aires, AR Macquarie Park, AU Macquarie Park, AU North Ryde, AU Wien, AT see more | Locations London, GB HQ Boumerdes, DZ Buenos Aires, AR Abbotsford, AU Wien, AT Wavre, BE Rio De Janeiro, BR see more |
Employees | Employees 18,726 | Employees 14,1002% increase | Employees 94,300 | Employees 68,629 |
Valuation ($) | Valuation ($) 61.7 b | Valuation ($) 82.1 b | Valuation ($) 2.7 b | Valuation ($) 862.5 m |
Financial | ||||
Revenue (est.) | Revenue (est.) ¥1.9t (FY, 2024) | Revenue (est.) $9.5b (FY, 2025) | Revenue (est.) $58.7b (FY, 2025) | Revenue (est.) £32.7b (FY, 2025) |
Cost of goods | Cost of goods ¥415.8b (FY, 2024) | Cost of goods $2.7b (FY, 2025) | Cost of goods $4.9b (FY, 2025) | Cost of goods £5.6b (FY, 2025) |
Gross profit | Gross profit ¥1.5t (FY, 2024) | Gross profit $6.8b (FY, 2025) | Gross profit $54.2b (FY, 2025) | Gross profit £28.5b (FY, 2025) |
Net income | Net income ¥295.8b (FY, 2024) | Net income N/A | Net income $10.2b (FY, 2025) | Net income £6.3b (FY, 2025) |
Operating ⚠ | ||||
Countries | Countries N/A | Countries 100 (Q3, 2021) | Countries 130 (FY, 2021) | Countries 92 (FY, 2021) |
Patent Applications | Patent Applications 367 (Jun, 2022) | Patent Applications 1.5 k (FY, 2020) | Patent Applications N/A | Patent Applications N/A |
Phase I Trials Products | Phase I Trials Products 16 (FY, 2018) | Phase I Trials Products N/A | Phase I Trials Products N/A | Phase I Trials Products 16 (FY, 2021) |
Phase II Trials Products | Phase II Trials Products 7 (FY, 2018) | Phase II Trials Products N/A | Phase II Trials Products N/A | Phase II Trials Products 6 (FY, 2021) |
Phase III Trials Products | Phase III Trials Products 7 (FY, 2018) | Phase III Trials Products N/A | Phase III Trials Products N/A | Phase III Trials Products 11 (FY, 2021) |
Trademarks | Trademarks 112 (Jun, 2022) | Trademarks 8.2 k (FY, 2020) | Trademarks N/A | Trademarks N/A |
For sources of this data, please see the company profile
View Company Profiles
Zoetis
HQ
Parsippany, US
Employees
14,100↑ 2% increase
Zoetis (formerly known as Pfizer Animal Health) is an animal health company focusing on the discovery, development, manufacture, and commercialization of medicines, vaccines, and diagnostic products and services.
View companyAstraZeneca
HQ
Cambridge, GB
Employees
94,300
AstraZeneca is a biopharmaceutical company specializing in the discovery, development, manufacturing, and marketing of prescription medicines.
View companyGSK
HQ
London, GB
Employees
68,629
GSK (GlaxoSmithKline) is a science-led healthcare company that researches, develops, and manufactures pharmaceutical medicines, vaccines, and consumer healthcare products.
View company